Dear Colleagues,
BioRxiv is the new home to pre-print publications for all disciplines
involved in clinical drug development and therapeutics! Check out the new Drug
Development and Clinical Therapeutics
http://connect.biorxiv.org/relate/content/52 (#ddct) channel on the
well-know BioRxiv http://biorxiv.org/ pre-print site (channels are listed
in a menu on the upper right side of the main page).
Pre-prints provide rapid dissemination of knowledge with an opportunity to
receive dynamic and continuous feedback from multiple reviewers that can
improve the quality of your publication.
We believe pre-prints are an essential but missing link in our rapidly
growing field of quantitative clinical sciences that support clinical drug
development and therapeutic management.
You can learn more about pre-prints
https://www.youtube.com/watch?v=2zMgY8Dx9co and Biorxiv
https://www.youtube.com/watch?v=EwAMtT3ZIpg by watching the videos in the
links.
Submitting your manuscripts to biorxiv’s #ddct channel requires 2 simple
steps:
1. Submit your manuscript through the regular submission route of
biorxiv that can be found here http://biorxiv.org/submit-a-manuscript
2. Add a #ddct Tag to the end of your manuscript abstract to get listed
in the Drug Development and Clinical Therapeutics channel
http://connect.biorxiv.org/relate/content/52. In addition to this tag,
you can include multiple other tags that are listed here
http://connect.biorxiv.org/relate/content/52 in the “Instructions for
authors”
Your manuscript will be sent out to moderators who will oversee the content
and approve the pre-print. The moderator’s job is primarily to ensure that
the manuscript is a rigorous scientific work in an area consistent with the
scope of the #ddct channel. Review of the details of the manuscript is left
to the community who have access to a discussion board for each manuscript.
This will facilitate an open peer review process designed to help authors
improve their work before submitting to a peer-reviewed journal. A revised
and refined manuscript after open peer-review can still be submitted to any
standard journal of your choice.
We are seeking moderators from different time zones around the world, at
least 1-2 from each continent. Moderators will serve for a one year term at
the end of which can nominate other colleagues to serve. If you would like
to nominate yourself or a colleague, please send an email to the contacts
listed below with the subject line - “Intent to moderate #ddct biorxiv”.
Please send all questions and comments to -
Vijay Ivaturi - [email protected]
Kyle Baron - [email protected]
Or join the discussion in the Biorxiv category thread on
http://discuss.go-isop.org/
Best regards,
Vijay Ivaturi
Kyle Baron
--
~Vijay